NeuroMetrix Announces Updates to Quell 2.0 Commercial Strategy
October 15, 2019 11:00 ET
|
NeuroMetrix, Inc.
WOBURN, Mass., Oct. 15, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), a health technology company that develops and commercializes products for the chronic pain and diabetes markets,...
NeuroMetrix, Inc. Announces Date for Third Quarter 2019 Financial Results Conference Call
October 10, 2019 11:00 ET
|
NeuroMetrix, Inc.
WOBURN, Mass., Oct. 10, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2019 third quarter financial results before the opening of the market on...
NeuroMetrix Reports Q2 2019 Financial Results
July 18, 2019 07:00 ET
|
NeuroMetrix, Inc.
WALTHAM, Mass., July 18, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended June 30, 2019. The Company develops and...
NeuroMetrix, Inc. Announces Date for Second Quarter 2019 Financial Results Conference Call
July 11, 2019 13:15 ET
|
NeuroMetrix, Inc.
WALTHAM, Mass., July 11, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2019 second quarter financial results before the opening of the market on...
NeuroMetrix Provides Strategic Update
June 27, 2019 07:00 ET
|
NeuroMetrix, Inc.
WALTHAM, Mass., June 27, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), a health technology company addressing chronic health conditions including chronic pain, sleep disorders and...
NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology
May 21, 2019 13:00 ET
|
NeuroMetrix, Inc.
WALTHAM, Mass., May 21, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,293,159 titled “Measuring the...
NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology
May 07, 2019 13:00 ET
|
NeuroMetrix, Inc.
WALTHAM, Mass., May 07, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,279,179 titled...
NeuroMetrix Reports Q1 2019 Financial Results
April 25, 2019 07:00 ET
|
NeuroMetrix, Inc.
WALTHAM, Mass., April 25, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), today reported financial and business highlights for the quarter ended March 31, 2019. The Company develops and...
NeuroMetrix, Inc. Announces Date for First Quarter 2019 Financial Results Conference Call
April 17, 2019 11:00 ET
|
NeuroMetrix, Inc.
WALTHAM, Mass., April 17, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2019 first quarter financial results before the opening of the market...
NeuroMetrix Reports New Clinical Studies Published on DPNCheck
January 29, 2019 13:00 ET
|
NeuroMetrix, Inc.
WALTHAM, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) today reported publication of three new DPNCheck® clinical studies. DPNCheck is a point-of-care test that provides...